Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
about
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancerThe prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significanceMolecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Role and mechanisms of resistance of epidermal growth factor receptor antagonists in the treatment of colorectal cancer.Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers.Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145.Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy.Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer.Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.
P2860
Q33574744-DA91E78F-8E80-4B8B-A114-CA983220B10AQ33679684-FE61FF17-9689-483D-86E1-AC04985250A6Q33768220-4E12764A-900A-4CBD-ABE9-89A3F5A58A6CQ36262967-547FFF95-26C3-48A2-B496-8FEA5B76B0EDQ37340755-791A2BA1-FBF7-446B-97A2-42042D151809Q37457496-6E7ED774-138B-4EF5-A828-2947E76355D3Q37525272-12B13768-ACDD-4018-BF5A-2B21298A112EQ38516244-2118F3EC-B211-452E-8B86-2EAE3DE44418Q38573698-271A91A4-77AA-419B-A8DD-49B8370DCC9BQ38778827-7EF9578C-BC9F-4A9A-830C-7834EBFEAAD3Q38828050-D92B7572-D256-41AF-9638-0D72212A8DB4Q39796293-B1884254-E6E1-4045-A7EA-9671BFE2CD50Q41198045-535A1167-9646-4A22-9778-28548ECCEC13Q41367522-CE2DA8DB-4A49-429C-B394-DFDB19CE6D8DQ42673285-2491FDB9-8BEC-4354-BE00-38C6EABAEACAQ47135773-83B723ED-E2E0-4F9A-A186-C1E9BDFDD2C1Q55028937-6B56C826-8EF5-4C89-9B7C-09E2299C7610Q55154129-2B6E37DA-7599-492A-BB66-DF93693DCB8CQ55342871-DC433F01-A5DC-4DC8-9BA4-EBA841BBD6A9
P2860
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@en
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@nl
type
label
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@en
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@nl
prefLabel
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@en
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
@en
P2093
Elena Masiero
Emiliana Iaiza
Gianpiero Fasola
Giovanna De Maglio
Giovanni Gerardo Cardellino
Giuseppe Aprile
Luisa Foltran
Mariella Giovannoni
Micol Mazzer
Nicoletta Pella
P2860
P304
P356
10.2217/FON.14.279
P407
P577
2015-01-01T00:00:00Z